A combination of disappointing data and urging by a panel of physicians against blockbuster cholesterol drug Vytorin dented two pharma giants, as the annual meeting of the American College of Cardiology (Washington) got under way in Chicago.

Merck and Schering knocked by Vytorin; 2-drug trial halt a plus

Name: Relias Media
Price range: $

January 2, 2015

Reprints

Recognizing, Managing, and Reporting Pediatric Sexual Abuse and Assault
Eleventh Circuit Affirms Jury Verdict of $2.5 Million for Mesh Device Plaintiff Despite Close Call on Statute of Limitations
Indiana Appellate Court Allows Case to Proceed Against Doctor Accused of Improperly Accessing Patients’ Medical Records
Malpractice Insurance Rates Increasing After Stable Period
Clinical Decision Software Highly Effective in OR